48 /100
MEDIUM RISK
Score updated Jul 14, 2026

TTRX — Turn Therapeutics Inc. Dilution Risk Tracker

Track TTRX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track TTRX — Get alerts when the score changes →

As of July 14, 2026, Turn Therapeutics Inc. (TTRX) has a DilutionWatch DilutionScore of 48/100, rated MEDIUM dilution risk. Turn Therapeutics Inc. has a market capitalization of $154.90M, 29.79M shares outstanding, 20 institutional holders tracked. Key dilution vectors include 1.19M outstanding warrants, approximately 52 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
0
📊 Float Risk
62
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for TTRX.
🔔 Track TTRX — Get forecast alerts →

💹 Market Data

Market Cap$154.90M
Shares Outstanding29.79M
Float11.13M
Cash$11.01M
Debt$5.94M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 11.9% shares (2026Q1 vs prior)
20 institutional holders · 521.8K shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 98.9K shares
#2 DDFG, Inc 70.5K shares
#3 MILLENNIUM MANAGEMENT LLC 69.8K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest38.5K
Days to Cover1.0
% of Float0.3%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2026
4 INSIDER TRANSACTION Apr 03, 2026
4 INSIDER TRANSACTION Apr 03, 2026
4 INSIDER TRANSACTION Apr 03, 2026
4 INSIDER TRANSACTION Apr 03, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for TTRX Shareholders

Turn Therapeutics Inc. (TTRX) has a DilutionScore of 48/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

DilutionWatch tracks 1.2M outstanding warrants for TTRX. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window.

DilutionWatch tracks over 25 SEC filing types for TTRX in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for TTRX alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Warrants Explained →
Track TTRX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking TTRX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for TTRX
📊 TTRX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 TTRX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.